Novartis strikes stem cell deal to aid transplant patients – FierceBiotech
|
Novartis strikes stem cell deal to aid transplant patients
FierceBiotech Swiss drugmaker Novartis ($NVS) said Friday that it has teamed up with small biotech outfit Regenerex, gaining access to stem cell technology designed to benefit organ transplant patients. Timothy Wright, head of development at Novartis Pharmaceuticals … |
